Research and Innovation

Home  >  Research and Innovation > Research at the UB > Institutes and research centres > Bellvitge Institute for Biomedical Research (IDIBELL)

Bellvitge Institute for Biomedical Research (IDIBELL)

IDIBELL logo

The Bellvitge Institute for Biomedical Research (IDIBELL) is a research foundation that was set up on 16 June 2004 as a separate legal entity, as a result of the change in name of the former August Pi i Sunyer Foundation (FAPS), which had been founded in 1988. IDIBELL has scientific cooperation agreements with the following institutions and centres:

  • The University of Barcelona (UB) and the Barcelona Science Park (PCB)
  • Bellvitge University Hospital (HUB)
  • Catalan Institute of Oncology (ICO)
  • Institute of Diagnostic Imaging (IDI)
  • Transfusion Centre and Tissue Bank (BST)

Six major areas or programs have been defined at IDIBELL:

  • Area 1. Cancer and human molecular genetics
  • Area 2. Neurosciences
  • Area 3. Infectious pathology and transplants
  • Area 4. Growth factors, hormones and diabetes
  • Area 5. Inflammatory, chronic and degenerative diseases
  • Area 6. Epigenetics and Cancer Biology

Further information

  • Institut d’Investigació Biomèdica de Bellvitge (IDIBELL)
  • Hospital Duran i Reynals (3a planta)
  • Gran Via de les Corts Catalanes, 199-203
  • 08907 l’Hospitalet de Llobregat
  • Tel. (+34) 932 607 775
  • Fax. (+34) 932 607 776
  • www.idibell.org
  • info@idibell.org
  • Director: Jaume Reventós
  • Follow us:
  • Button to access University of Barcelona's Facebook profile
  • Button to access University of Barcelona's Twitter profile
  • Button to access University of Barcelona's Youtube profile
  • Button to access University of Barcelona's RSS
Member of: Two Campuses of International Excellence logo del leru - League of European Research Universities logo del bkc - campus excel·lència logo del health universitat de barcelona campus

© 2013 Universitat de Barcelona